Skip to main content

Table 1 Characteristics of 461 patients with PPC

From: Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study

Variable

Value (461)

≤ 66 years

> 66 years

Total number

p

Gender

   

0.038

male

144 (63%)

125 (54%)

269 (58%)

 

Female

84 (37%)

108 (46%)

192 (42%)

 

Marital status

   

0.000

Married

116 (51%)

119 (51%)

235 (51%)

 

Single (unmarried)

46 (20%)

13 (6%)

59 (13%)

 

Separated/divorced/widowed

66 (29%)

101 (43%)

167 (36%)

 

Race

   

0.000

White

164 (72%)

206 (88%)

370 (80%)

 

Black

51 (22%)

13 (6%)

64 (14%)

 

Other

13 (6%)

14 (6%)

27 (6%)

 

Laterality

   

0.315

Left

88 (39%)

106 (45%)

194 (42%)

 

Right

128 (56%)

115 (49%)

243 (53%)

 

Bilateral

12 (5%)

12 (5%)

24 (5%)

 

Primary site

   

0.233

Upper lobe, lung

135 (59%)

124 (53%)

259 (56%)

 

Lower lobe, lung

43 (19%)

56 (24%)

99 (22%)

 

Main bronchus

7 (3%)

2 (1%)

9 (2%)

 

Middle lobe, lung

10 (4%)

12 (5%)

22 (5%)

 

Overlapping lesion of lung

33 (14%)

39 (17%)

72 (16%)

 

Summary stage

   

0.530

Localized

35 (15%)

45 (19%)

80 (17%)

 

Regional

86 (38%)

83 (36%)

169 (37%)

 

Distant

107(47%)

105 (45%)

212 (46%)

 

Surgery

   

0.742

Yes

117 (51%)

116 (50%)

233 (51%)

 

No

111 (49%)

117 (50%)

228 (59%)

 

Radiation

   

0.001

Yes

95 (42%)

63 (27%)

158 (34%)

 

No

133 (58%)

170 (73%)

303 (66%)

 

Chemotherapy

   

< 0.001

Yes

114 (50%)

62 (27%)

176 (38%)

 

No

114 (50%)

171(73%)

285 (62%)

 
  1. Statistical analyses were performed using SPSS
  2. Bold means statistically significant value p < 0.05